Analyze Diet
Journal of veterinary internal medicine2023; doi: 10.1111/jvim.16821

The effects of orally administered trazodone on ambulation and recumbency in healthy horses.

Abstract: Trazodone, a serotonin receptor antagonist and reuptake inhibitor, might be a useful adjunctive treatment in the initial management of horses with acute laminitis if it minimizes ambulation or encourages recumbency. Objective: (1) Evaluate the effects of PO trazodone on ambulatory activity and recumbency in healthy horses; and (2) assess the pharmacokinetics of multiple PO doses of trazodone. Methods: In a randomized cross-over design, 8 healthy horses received placebo or trazodone at 2 doses (2.5 and 7.5 mg/kg) PO q12h for 48 hours with a 14-day washout period between treatments. Forelimb step frequency was measured using a hoof-mounted accelerometer and continuous video monitoring was used to detect recumbency. Groups were compared using repeated measures analysis of variance with Tukey's post hoc test. Trazodone and m-chlorophenylpiperazine (m-CPP) plasma concentrations were determined by ultra-high performance liquid chromatography-tandem mass spectrometry and pharmacokinetics were analyzed using noncompartmental methods. Results: Step frequency was lower in horses receiving 7.5 mg/kg trazodone than in the control group (mean step reduction: 44% ± 11%). Steps-area under the curve were significantly lower in the 7.5 mg/kg group (mean ± SD: 3375 ± 525 steps × hour) as compared to the 2.5 mg/kg group (mean ± SD: 5901 ± 2232; P = .02) and compared to control (mean ± SD: 6590 ± 1241; P = .001). No difference was found in the number of recumbent episodes (P = .92) or total duration of recumbency (P = .9). Trazodone and m-CPP achieved steady-state concentrations, with an accumulation ratio of 1.45 ± 0.2. Conclusions: Although it did not affect recumbency, trazodone at 7.5 mg/kg q12h decreased step frequency by approximately 44%.
Publication Date: 2023-07-25 PubMed ID: 37489582DOI: 10.1111/jvim.16821Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study explored whether giving horses a drug called Trazodone could make them move less and lie down more, which could help treat a painful foot condition. The drug reduced the horses’ steps but didn’t make them lie down more.

Background

  • Trazodone is a drug that affects serotonin, a chemical in the brain.
  • It’s believed that Trazodone might help in treating horses with acute laminitis (a painful foot condition) by reducing their movement or making them lie down more.

Objective

  • Check how Trazodone, when given orally (PO), affects the movement and lying down behavior of healthy horses.
  • Study the drug’s behavior in the body (pharmacokinetics) after giving multiple oral doses.

Methods

  • Using a specific study design, 8 healthy horses were randomly given either a placebo or Trazodone in two different doses. This was done twice a day for 2 days. There was a 14-day break between treatments.
  • They used a device on the horse’s hoof and video monitoring to count steps and see when the horses lay down.
  • They used statistical methods to compare the groups.
  • The levels of Trazodone and another related compound in the blood were measured using advanced techniques. They also studied how the drug behaved in the body.

Results

  • Horses that received the higher dose of Trazodone (7.5 mg/kg) took fewer steps than those in the control group.
  • When they compared the total number of steps over time, the high-dose group had significantly fewer steps than both the low-dose group and the control group.
  • There was no change in the number or duration of times the horses lay down.
  • The drug reached consistent levels in the blood, with a specific accumulation ratio.

Conclusions

  • While Trazodone didn’t make the horses lie down more, it did reduce their steps by about 44% when given at the higher dose of 7.5 mg/kg twice a day.

Cite This Article

APA
Hobbs K, Luethy D, Davis J, Mallicote M, Torcivia C, Kulp J, Stefanovski D, Futterman C, Cooper F, van Eps A. (2023). The effects of orally administered trazodone on ambulation and recumbency in healthy horses. J Vet Intern Med. https://doi.org/10.1111/jvim.16821

Publication

ISSN: 1939-1676
NlmUniqueID: 8708660
Country: United States
Language: English

Researcher Affiliations

Hobbs, Kallie
  • Department of Large Animal Clinical Sciences, University of Florida College of Veterinary Medicine, Gainesville, Florida, USA.
Luethy, Daniela
  • Department of Large Animal Clinical Sciences, University of Florida College of Veterinary Medicine, Gainesville, Florida, USA.
Davis, Jennifer
  • Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Blacksburg, Virginia, USA.
Mallicote, Martha
  • Department of Large Animal Clinical Sciences, University of Florida College of Veterinary Medicine, Gainesville, Florida, USA.
Torcivia, Catherine
  • Department of Clinical Studies-New Bolton Center, School of Veterinary Medicine, University of Pennsylvania, Kennett Square, Pennsylvania, USA.
Kulp, Jeaneen
  • Department of Clinical Studies-New Bolton Center, School of Veterinary Medicine, University of Pennsylvania, Kennett Square, Pennsylvania, USA.
Stefanovski, Darko
  • Department of Clinical Studies-New Bolton Center, School of Veterinary Medicine, University of Pennsylvania, Kennett Square, Pennsylvania, USA.
Futterman, Catherine
  • Department of Large Animal Clinical Sciences, University of Florida College of Veterinary Medicine, Gainesville, Florida, USA.
Cooper, Freya
  • Department of Large Animal Clinical Sciences, University of Florida College of Veterinary Medicine, Gainesville, Florida, USA.
van Eps, Andrew
  • Department of Clinical Studies-New Bolton Center, School of Veterinary Medicine, University of Pennsylvania, Kennett Square, Pennsylvania, USA.

References

This article includes 19 references
  1. van Eps AW, Burns TA. Are there shared mechanisms in the pathophysiology of different clinical forms of laminitis and what are the implications for prevention and treatment?. Vet Clin North Am Equine Pract 2019;35:379-398.
  2. Mitchell CF, Fugler LA, Eades SC. The management of equine acute laminitis. Vet Med (Auckl) 2015;6:39-47.
  3. Wattle O, Ekfalck A, Funkquist B, Obel N. Behavioural studies in healthy ponies subjected to short-term forced recumbency aiming at an adjunctive treatment in an acute attack of laminitis. Zentralbl Veterinarmed A 1995;42:62-68.
  4. Fontenot RL, Mochal-King CA, Sprinkle SB, Wills RW, Calder CD. Retrospective evaluation of fluoxetine hydrochloride use in horses: 95 cases (2010-2019). J Equine Vet Sci 2021;97:103340.
  5. Lloyd KC, Harrison I, Tulleners E. Reserpine toxicosis in a horse. J Am Vet Med Assoc 1985;186:980-981.
  6. Moss AL, Hritz RL, Hector RC, Wotman KL. Investigation of the effects of orally administered trazodone on intraocular pressure, pupil diameter, physical examination variables, and sedation level in healthy equids. Am J Vet Res 2021;82:138-143.
  7. Davis JL, Schirmer J, Medlin E. Pharmacokinetics, pharmacodynamics and clinical use of trazodone and its active metabolite m-chlorophenylpiperazine in the horse. J Vet Pharmacol Ther 2018;41:393-401.
  8. Tellone V, Rosignoli MT, Picollo R. Effect of 3 single doses of trazodone on QTc interval in healthy subjects. J Clin Pharmacol 2020;60:1483-1495.
  9. Trachsel DS, Calloe K, Rgensen EJ. Evaluation of electrocardiographic repolarization parameters after administration of trimethoprim-sulfadiazine, detomidine, or their combination in horses. Am J Vet Res 2021;82:207-217.
  10. Pedersen PJ, Karlsson M, Flethøj M. Differences in the electrocardiographic QT interval of various breeds of athletic horses during rest and exercise. J Vet Cardiol 2016;18:255-264.
  11. Prud'homme Y, Ferrell ST, Beaudry F, Beauchamp G, Nichols S, Desmarchelier M. Pharmacokinetics and clinical effects of a single oral dose of trazodone in the domestic goat (capra hircus) as a model for wild ruminants. J Zoo Wildl Med 2021;51:896-904.
  12. Gruen ME, Roe SC, Griffith E, Hamilton A, Sherman BL. Use of trazodone to facilitate postsurgical confinement in dogs. J Am Vet Med Assoc 2014;245:296-301.
  13. Jay AR, Krotscheck U, Parsley E. Pharmacokinetics, bioavailability, and hemodynamic effects of trazodone after intravenous and oral administration of a single dose to dogs. Am J Vet Res 2013;74:1450-1456.
  14. Knych HK, Mama KR, Steffey EP, Stanley SD, Kass PH. Pharmacokinetics and selected pharmacodynamics of trazodone following intravenous and oral administration to horses undergoing fitness training. Am J Vet Res 2017;78:1182-1192.
  15. Fries RC, Kadotani S, Vitt JP, Schaeffer DJ. Effects of oral trazodone on echocardiographic and hemodynamic variables in healthy cats. J Feline Med Surg 2019;21:1080-1085.
  16. Vatassery GT, Holden LA, Hazel DK, Dysken MW. Determination of trazodone and its metabolite, 1-m-chlorophenyl-piperazine, in human plasma and red blood cell samples by HPLC. Clin Biochem 1997;30:149-153.
  17. Mitchell PB. Therapeutic drug monitoring of non-tricyclic antidepressant drugs. Clin Chem Lab Med 2004;42:1212-1218.
  18. The University of Iowa Department of Pathology Laboratory Services Handbook, Trazodone Drug Level. Iowa: University of Iowa Healthcare; 2022. https://www.healthcare.uiowa.edu/path_handbook/handbook/test774.html
  19. Lee S, Lee HA, Kim SJ, Kim KS. Cellular mechanisms for trazodone-induced cardiotoxicity. Hum Exp Toxicol 2016;35:501-510.

Citations

This article has been cited 3 times.
  1. Klinck M, Lovett A, Sykes B. Incorporating a Behavioral Medicine Approach in the Multi-Modal Management of Chronic Equine Gastric Ulcer Syndrome (EGUS): A Clinical Commentary. Animals (Basel) 2025 Oct 17;15(20).
    doi: 10.3390/ani15203019pubmed: 41153946google scholar: lookup
  2. Joseph EJ, Love L, Mayakis M, Varner K. Preanesthetic Administration of Trazodone Does Not Impact Anesthetic Recovery Scores in Horses. Animals (Basel) 2025 Oct 6;15(19).
    doi: 10.3390/ani15192907pubmed: 41096502google scholar: lookup
  3. Chow L, Kawahisa-Piquini G, Bass L, Hendrickson D, Patel A, Rockow M, Dow S, Pezzanite LM. Correlation of fecal microbiome dysregulation to synovial transcriptome in an equine model of obesity associated osteoarthritis. Ann Transl Med 2024 Dec 24;12(6):112.
    doi: 10.21037/atm-24-109pubmed: 39817240google scholar: lookup